Skip to content

Understanding DSC Deconvolution

DSC-MRI uses deconvolution to extract perfusion parameters from the measured signal.

The Measurement

DSC-MRI tracks a gadolinium bolus through brain tissue using T2*-weighted imaging. The signal drops as contrast passes through:

DSC signal-time curve showing signal drop during gadolinium bolus passage.

From Signal to Concentration

T2* Signal Model

Gadolinium causes T2* shortening:

\[ S(t) = S_0 \cdot e^{-TE \cdot \Delta R_2^*(t)} \]

Solving for ΔR2*:

\[ \Delta R_2^*(t) = -\frac{1}{TE} \ln\left(\frac{S(t)}{S_0}\right) \]

Concentration Relationship

ΔR2* is proportional to contrast concentration:

\[ \Delta R_2^*(t) = r_2^* \cdot C(t) \]

Where r2* is the transverse relaxivity (osipy defaults: 32 s⁻¹mM⁻¹ for tissue, 50 s⁻¹mM⁻¹ for blood at 1.5T).

The Indicator Dilution Problem

Tissue Response

The tissue concentration C(t) is the convolution of the arterial input function (AIF) with a tissue response:

\[ C(t) = CBF \cdot \left[ C_{AIF}(t) \otimes R(t) \right] \]

Where R(t) is the residue function (fraction of contrast remaining in tissue).

What is the Residue Function?

R(t) describes how contrast leaves tissue:

Residue function R(t) decaying from 1 toward 0, with MTT marked.

  • R(0) = 1: All contrast is present initially
  • R(∞) = 0: Eventually all contrast leaves
  • Shape depends on vasculature

The Deconvolution Problem

Forward Problem (Easy)

Given CBF, AIF, and R(t), calculate C(t):

\[ C(t) = CBF \cdot \int_0^t C_{AIF}(\tau) \cdot R(t-\tau) d\tau \]

Inverse Problem (Hard)

Given C(t) and AIF, find CBF and R(t):

\[ R(t) = \frac{1}{CBF} \cdot \text{deconvolution}[C(t), C_{AIF}(t)] \]

This is ill-posed: small noise causes large errors.

Matrix Formulation

Discrete Convolution

In discrete form, convolution becomes matrix multiplication:

\[ \mathbf{C} = CBF \cdot \mathbf{A} \cdot \mathbf{R} \]

Where:

\[ \mathbf{A} = \begin{pmatrix} C_{AIF}(0) & 0 & 0 & \cdots \\ C_{AIF}(1) & C_{AIF}(0) & 0 & \cdots \\ C_{AIF}(2) & C_{AIF}(1) & C_{AIF}(0) & \cdots \\ \vdots & & & \ddots \end{pmatrix} \cdot \Delta t \]

Solving the System

The deconvolution is:

\[ \mathbf{R} = \frac{1}{CBF} \cdot \mathbf{A}^{-1} \cdot \mathbf{C} \]

But A⁻¹ amplifies noise → need regularization.

SVD-Based Deconvolution

Why SVD?

Singular Value Decomposition provides a stable way to invert A:

\[ \mathbf{A} = \mathbf{U} \cdot \mathbf{S} \cdot \mathbf{V}^T \]

Where S is diagonal with singular values σ₁ > σ₂ > ... > σₙ.

Truncation for Regularization

Small singular values amplify noise. Solution: truncate them.

\[ \mathbf{A}^{-1}_{truncated} = \mathbf{V} \cdot \mathbf{S}^{-1}_{truncated} \cdot \mathbf{U}^T \]

Where σᵢ < threshold × σ₁ are set to zero.

Deconvolution Methods

sSVD (Standard SVD)

Direct SVD of the convolution matrix:

  • Pros: Simple, widely used
  • Cons: Sensitive to bolus delay
  • Threshold: Typically 0.1-0.2

cSVD (Circular SVD)

Uses block-circulant matrix (assumes periodic signal):

  • Pros: Delay-insensitive
  • Cons: May underestimate CBF
  • Note: Commonly used in clinical software

oSVD (Oscillation-Index SVD)

Selects threshold based on oscillation in R(t):

  • Pros: Adaptive, noise-tolerant
  • Cons: More complex
  • Criterion: Minimize oscillations while preserving CBF

oSVD oscillation index optimization

# oSVD optimizes threshold to minimize oscillation index:
OI = (1/R_max) * sum(|R(i+1) - R(i)|)
# Choose threshold that balances low OI with accurate CBF

Extracting Perfusion Parameters

From the Residue Function

Once R(t) is estimated:

Parameter Calculation
CBF max(R(t)) × scaling factor
CBV Area under C(t) ÷ Area under AIF
MTT CBV / CBF (central volume theorem)
Tmax Time to maximum of R(t)
TTP Time to minimum of S(t)

CBF Calculation

CBF = max[CBF × R(t)] = CBF × max[R(t)]

If R(t) is properly normalized (R(0)=1):

\[ CBF = max(\mathbf{R}) \]

CBV Calculation

From conservation of tracer:

\[ CBV = \frac{\int_0^\infty C_{tissue}(t) dt}{\int_0^\infty C_{AIF}(t) dt} = \frac{AUC_{tissue}}{AUC_{AIF}} \]

MTT via Central Volume Theorem

The Central Volume Theorem relates:

\[ MTT = \frac{CBV}{CBF} \]

This is a fundamental relationship in indicator dilution theory.

Delay and Dispersion

Bolus Delay

If tissue is fed by a delayed artery:

  • Signal arrives later
  • Standard deconvolution interprets this as low CBF
  • Use cSVD or delay-corrected methods

Side-by-side comparison of AIF and delayed tissue concentration curves.

Bolus Dispersion

As blood flows through vessels, the bolus spreads:

  • Peak concentration decreases
  • Duration increases
  • Affects CBF estimation

Leakage Correction

The Problem

In tumors with BBB breakdown, contrast leaks into tissue:

  1. T1 effect: Leakage increases signal (opposite to T2* effect)
  2. T2* contamination: Altered concentration curve

Boxerman-Schmainda-Weisskoff (BSW) Correction

Models the leakage contribution:

\[ \Delta R_2^*(t) = K_1 \cdot \overline{\Delta R_2^*_{brain}}(t) + K_2 \cdot \int_0^t \overline{\Delta R_2^*_{brain}}(\tau) d\tau \]

Where:

  • K₁: Reflects residual T2* effects
  • K₂: Reflects T1 leakage contamination

Practical Considerations

AIF Selection

Critical for accurate deconvolution:

  • Should represent input to tissue
  • Avoid partial volume with tissue
  • Consider delay to imaging region

Threshold Selection

For SVD truncation:

  • Too high: Smooths R(t), underestimates CBF
  • Too low: Noisy R(t), unreliable parameters

Typical range: 0.05-0.20 relative to σ₁

Normalization

Results may need normalization:

  • rCBV: CBV relative to white matter
  • Accounts for intersubject AIF variability

Clinical Applications

Stroke

Perfusion maps help identify:

  • Infarct core: Very low CBF, CBV
  • Penumbra: Low CBF, maintained CBV
  • Tmax delay: Indicator of collateral flow

Tumors

DSC provides:

  • rCBV: Correlates with tumor grade
  • Leakage: Indicates BBB breakdown
  • Response assessment: Changes with treatment

References

  1. Østergaard L et al. "High resolution measurement of cerebral blood flow using intravascular tracer bolus passages." Magn Reson Med 1996.

  2. Wu O et al. "Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix." Magn Reson Med 2003.

  3. Boxerman JL et al. "Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade." AJNR 2006.

See Also